Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Donald E Kohan

7PUBLICATIONS

8CO-AUTHORS

Developmental genetics (incl. sex determination)Respiratory diseasesClinical nutritionEpigenetics (incl. genome methylation and epigenomics)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Dec 11, 2024

Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.

J David Smeijer, Sieta T de Vries, Donald E Kohan

|May 09, 2023

Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan.

J David Smeijer, Donald E Kohan, Dick de Zeeuw

|May 04, 2023

Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease.

Donald E Kohan, Adrian Liew, Sydney C W Tang

|Jul 27, 2022

Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease.

J David Smeijer, Jeroen V Koomen, Donald E Kohan

|Mar 11, 2022

Profiling renal sodium transporters in mice with nephron Ift88 disruption: Association with sex, cysts, and blood pressure.

Chunyan Hu, Jayalakshmi Lakshmipathi, Deborah Stuart

|Dec 20, 2021

Multiomic identification of factors associated with progression to cystic kidney disease in mice with nephron Ift88 disruption.

Chunyan Hu, Katherine Beebe, Edgar J Hernandez

Pageof 2

Frequent Collaborators

3 joint publications

J David Smeijer

3 joint publications

Hiddo J L Heerspink

2 joint publications

Fan-Fan Hou

1 joint publications

Jose M Lazaro-Guevara

1 joint publications

Jeroen V Koomen

1 joint publications

George L Bakris

1 joint publications

Michal Nowicki

1 joint publications

Sieta T de Vries

Frequent Collaborators

3 joint publications

J David Smeijer

3 joint publications

Hiddo J L Heerspink

2 joint publications

Fan-Fan Hou

1 joint publications

Jose M Lazaro-Guevara

Top Related Videos

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on : Mar 11, 2016

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on : May 06, 2018

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

See more related videos

Top Related Videos

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on : Mar 11, 2016

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on : May 06, 2018

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

See more related videos